Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 7, 2010

Broad Institute to Replace Illumina’s Genome Analyzer IIx Systems with HiSeq 2000 Units

  • The Broad Institute has purchased 51 HiSeq 2000s, Illumina's high-throughput next-generation sequencing system. These will be shipped over the next several quarters, Illumina says, and will replace an equal number of Genome Analyzer IIx systems.

    “We believe that the HiSeq 2000s will significantly increase our capabilities in high-throughput genomics, as our experience with early access instruments has already produced multiple runs in excess of 250 Gb of data and yielded significant improvements in lab workflow,” remarks Robert Nicol, Ph.D., director of sequencing operations and technology development at the Broad Institute. “Coupled with Illumina's newest sequencing chemistry, the system has the potential to increase high-quality base yields at longer read lengths and could help improve mapping accuracy and variant discovery.”

    The compatibility of HiSeq 2000 sample preparation and data analysis with that of the Genome Analzyer IIx system allows organizations to seamlessly introduce the HiSeq systems into their existing sequencing infrastructures, Illumina asserts. The HiSeq 2000 sequencing system leverages Illumina's reversible terminator-based sequencing by synthesis chemistry in combination.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Pharmacists and Prescription Drug Misuse Programs

Do you agree that pharmacists should make a greater effort to become more involved with prescription drug-monitoring programs?

More »